John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Twenty-Five Year Experience With the St

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Double-Orifice Left Atrioventricular Valve in Patients With Atrioventricular Septal Defects: Surgical Strategies and Outcome Vikas Sharma, MD, Harold.

Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease Kenji Kuwaki, MD, PhD, Nobuyoshi Kawaharada,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing Jess L. Thompson, MD, Harold M. Burkhart, MD,

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Successful Robot-Assisted Repair of Congenital Mitral Valve Regurgitation Vijayakumar Raju, MD, Harold M. Burkhart, MD, Frank Cetta, MD, Rakesh M. Suri,

Reoperation After Mitral Valve Repair for Degenerative Disease

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Long-Term Follow-Up After Thoracoabdominal Aortic Aneurysm Repair

Outcomes of Early Mitral Valve Reoperation in the Medicare Population

Impact of Left Ventricular Systolic Function on Outcome of Correction of Chronic Severe Aortic Valve Regurgitation: Implications for Timing of Surgical.

Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Extracorporeal Membrane Oxygenation Support in Postcardiotomy Elderly Patients: The Mayo Clinic Experience Pankaj Saxena, FRACS, PhD, James Neal, CCP,

Quadruple valve replacement in patients with carcinoid heart disease

Outcome of Surgical Repair of Pulmonary Artery Aneurysms: A Single-Center Experience With 38 Patients Janani S. Reisenauer, MD, Sameh M. Said, MD, Hartzell.

Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period Hong Ju Shin, MD, Young-Hwue Kim,

Management of Mild Aortic Stenosis at the Time of Coronary Artery Bypass Surgery: Should the Valve Be Replaced? Basar Sareyyupoglu, MD, Thoralf M. Sundt,

Are older patients with mechanical heart valves at increased risk?

Pankaj Saxena, FRACS, PhD, Lyle D. Joyce, MD, PhD, Richard C

Surgical ablation for atrial fibrillation for two decades: Are the results of new techniques equivalent to the Cox maze III procedure? John M. Stulak,

Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M

Kevin L. Greason, MD, Brian D. Lahr, MS, John M

When should a mechanical tricuspid valve replacement be considered?

Mohammad A. Zafar, MBBS, Emily A

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Salah E. Altarabsheh, MD, Joseph A. Dearani, MD, Harold M

Juan G. Penaranda, MD, Kevin L. Greason, MD, Sorin V

John M. Stulak, MD, Rakesh M. Suri, MD, DPhil, Joseph A

Surgical Management of Anomalous Aortic Origin of a Coronary Artery

Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation Morgan L. Brown,

Vikas Sharma, MBBS, Harold M. Burkhart, MD, Joseph A

Survival Advantage and Improved Durability of Mitral Repair for Leaflet Prolapse Subsets in the Current Era Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff,

Surgical Strategy for Atrioventricular Septal Defect and Tetralogy of Fallot or Double- Outlet Right Ventricle Vijayakumar Raju, MD, Harold M. Burkhart,

Correction of Tetralogy of Fallot and of Pulmonary Atresia with Ventricular Septal Defect in Adults Jürgen Hörer, MD, Julia Friebe, MD, Christian Schreiber,

Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.

Dana Y. Fuhrman, DO, MS, Lan G

Sameh M. Said, MD, Harold M. Burkhart, MD, Hartzell V

Invited Commentary The Annals of Thoracic Surgery

Composite Valve Graft Replacement of the Aortic Root: Twenty-Seven Years of Experience at One Japanese Center Tomohiro Tsunekawa, MD, Hitoshi Ogino,

Cardiac Myxomas: A 50-Year Experience With Resection and Analysis of Risk Factors for Recurrence Ishan K. Shah, MD, Joseph A. Dearani, MD, Richard C.

Late Outcomes for Surgical Repair of Supravalvar Aortic Stenosis

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures Simon Maltais, MD, PhD,

John M. Stulak, MD, Thoralf M. Sundt, MD, Joseph A

A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: Should hemodynamic performance influence device selection? Rakesh.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Wilson Y. Szeto, MD, Joseph E. Bavaria, MD, Frank W

John M. Stulak, MD, Harold M. Burkhart, MD, Joseph A

Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E

Simulation-Based Postcardiotomy Extracorporeal Membrane Oxygenation Crisis Training for Thoracic Surgery Residents Harold M. Burkhart, MD, Jeffrey B.

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? Asvin M. Ganapathi,

Risk of Valve-Related Events After Aortic Valve Repair

Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,

Presentation transcript:

The Increasing Use of Mechanical Pulmonary Valve Replacement Over a 40-Year Period John M. Stulak, MD, Joseph A. Dearani, MD, Harold M. Burkhart, MD, Heidi M. Connolly, MD, Carole A. Warnes, MD, Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff, MD The Annals of Thoracic Surgery Volume 90, Issue 6, Pages 2009-2015 (December 2010) DOI: 10.1016/j.athoracsur.2010.07.023 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall actuarial survival for patients who have undergone mechanical pulmonary valve replacement is shown (dashed line). Survival curves for patients with carcinoid heart disease (square dots) and congenital heart disease (solid line) are also shown. There was no significant difference in survival according to diagnosis (p = 0.072). The Annals of Thoracic Surgery 2010 90, 2009-2015DOI: (10.1016/j.athoracsur.2010.07.023) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall actuarial survival curves are shown for patients who have undergone mechanical pulmonary valve replacement (solid line) and bioprosthetic pulmonary valve replacement (square dots). The groups were matched for age, gender, and diagnosis. There was no statistically significant difference between groups (p = 0.1). The Annals of Thoracic Surgery 2010 90, 2009-2015DOI: (10.1016/j.athoracsur.2010.07.023) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall actuarial survival curves are shown for patients with a congenital diagnosis who have undergone mechanical pulmonary valve replacement (solid line) and bioprosthetic pulmonary valve replacement (square dots). The groups were matched for age and gender. There was no statistically significant difference between groups (p = 0.18). The Annals of Thoracic Surgery 2010 90, 2009-2015DOI: (10.1016/j.athoracsur.2010.07.023) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Overall actuarial freedom from reoperation curves are shown for patients who have undergone mechanical pulmonary valve replacement (solid line) and bioprosthetic pulmonary valve replacement (square dots). The groups were matched for age, gender, and diagnosis. There was a statistically significant difference between groups (p = 0.018). The Annals of Thoracic Surgery 2010 90, 2009-2015DOI: (10.1016/j.athoracsur.2010.07.023) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions